Electroporation

DEVICE6 trials

Conditions

AFAblation of Atrial FibrillationAnal Intraepithelial NeoplasiaHIV PositivityHead Neck CancerHigh Grade Squamous Intraepithelial NeoplasiaHuman Papillomavirus-16 PositiveHuman Papillomavirus-18 Positive

Phase 1

Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

CompletedNCT02514421

The University of Texas Health Science Center, HoustonPancreatic Adenocarcinoma

Start: 2015-07-31End: 2017-04-18Updated: 2019-04-29

Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

WithdrawnNCT02592395

The University of Texas Health Science Center, HoustonPancreatic Adenocarcinoma

Start: 2015-10-31End: 2017-10-31Updated: 2018-10-17

Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas

NCT02822066

First Affiliated Hospital of Zhejiang UniversityRefractory Neoplasms

Start: 2016-04-30End: 2018-06-30Target: 60Updated: 2016-07-04

Calcium Electroporation for Head and Neck Cancer

NCT03051269

Rigshospitalet, DenmarkHead Neck Cancer

Start: 2016-05-31End: 2019-02-28Target: 6Updated: 2017-02-13

Phase 2

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

CompletedNCT03603808

AIDS Malignancy ConsortiumAnal Intraepithelial Neoplasia, High Grade Squamous Intraepithelial Neoplasia, HIV Positivity +2

Start: 2018-09-21End: 2025-06-17Updated: 2025-07-16

Unknown Phase

Comparison of Different Electroporation Systems in the Ablation Treatment of Atrial Fibrillation

Active, not recruitingNCT06646887

University Hospital DubravaAblation of Atrial Fibrillation, AF

Start: 2024-10-15End: 2025-05-01Target: 150Updated: 2025-04-01

Related Papers

Irreversible electroporation ablation of end‑stage metastatic retroperitoneal lesions: Report on three cases and literature review